Informations sur le produit
Nom:NLG919
Marque:Biosynth
Description :NLG919 is a small molecule that inhibits the enzyme IDO1, which is responsible for the breakdown of tryptophan. This inhibition results in increased levels of tryptophan and increased production of tumor necrosis factor-α (TNF-α), which has been shown to have significant cytotoxicity on prostate cancer cells. NLG919 also has potential to be an immunotherapy agent, as it induces antibodies against tumor cells. The proposed mechanism of action for NLG919 is based on its ability to inhibit IDO1 and TNF-α production, which can lead to tumor regression.
Avis:Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Propriétés chimiques
Masse moléculaire :282.38 g/mol
Formule :C18H22N2O
Degré de pureté :Min. 95%
Couleur/Forme :Solid
InChI :InChI=1S/C18H22N2O/c21-18(13-6-2-1-3-7-13)10-16-14-8-4-5-9-15(14)17-11-19-12-20(16)17/h4-5,8-9,11-13,16,18,21H,1-3,6-7,10H2
Code InChI :InChIKey=YTRRAUACYORZLX-UHFFFAOYSA-N
SMILES :OC(CC1c2ccccc2-c2cncn21)C1CCCCC1